---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-21-020884"
form_type: "8-K"
ticker: "NAGE"
cik: "0001386570"
company_name: "Niagen Bioscience, Inc."
filed_at: "2021-10-29T23:59:59+00:00"
generated_at: "2026-06-28T16:10:03.666493+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# ChromaDex director Tony Lau resigns; Champion River to nominate successor

## Summary
- Tony Lau notified ChromaDex of his resignation from the Board and Compensation Committee on Oct 19, 2021; effective date not yet determined.
- Resignation not due to any disagreement with the company; follows Lau's resignation from his position at Horizon Ventures.
- Champion River Ventures, which nominated Lau, intends to nominate a replacement director under the 2017 Securities Purchase Agreement.
- Lau's departure is unrelated to company operations, policies, or practices.

## SEC filing metadata
- accession: 0001628280-21-020884
- form_type: 8-K
- ticker: NAGE
- cik: 0001386570
- company_name: Niagen Bioscience, Inc.
- filed_at: 2021-10-29T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1386570/000162828021020884/0001628280-21-020884-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1386570/000162828021020884/cdxc-20211019.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-21-020884
- JSON: https://secwatch.observer/filing/0001628280-21-020884.json
- Plain text: https://secwatch.observer/filing/0001628280-21-020884.txt

## Key facts
- Executive change
  Tony Lau resigned as director at Niagen Bioscience, Inc..
  - Action: resigned
  - Role: director
  source text: On October 19, 2021, Tony Lau notified ChromaDex Corporation (the “Company”) of his intention to resign from the board of directors of the Company (the “Board”) and as a member of the Compensation Committee of the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1386570/000162828021020884/0001628280-21-020884-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.